Compare UI & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | UI | IQV |
|---|---|---|
| Founded | 2003 | 1982 |
| Country | United States | United States |
| Employees | N/A | 93000 |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 43.1B |
| IPO Year | 2011 | 2013 |
| Metric | UI | IQV |
|---|---|---|
| Price | $564.26 | $266.00 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 20 |
| Target Price | ★ $734.50 | $309.76 |
| AVG Volume (30 Days) | 68.6K | ★ 1.1M |
| Earning Date | 11-10-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | ★ 34.78 | 4.67 |
| EPS | ★ 15.85 | 5.24 |
| Revenue | $2,573,545,000.00 | ★ $9,739,000,000.00 |
| Revenue This Year | $22.01 | $7.12 |
| Revenue Next Year | $14.64 | $6.39 |
| P/E Ratio | ★ $38.20 | $52.36 |
| Revenue Growth | 33.45 | ★ 41.60 |
| 52 Week Low | $500.23 | $154.50 |
| 52 Week High | $1,099.99 | $284.50 |
| Indicator | UI | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 39.89 | 46.98 |
| Support Level | $544.69 | $252.55 |
| Resistance Level | $563.46 | $274.49 |
| Average True Range (ATR) | 21.80 | 9.53 |
| MACD | -4.60 | -0.17 |
| Stochastic Oscillator | 3.88 | 21.45 |
Ubiquiti Inc develops and sells networking equipment and provides related software platforms through distributors, online retailers, and its web stores. The Company develops technology platforms for high-capacity distributed Internet access and secure, easily managed network infrastructure, including connected sensors, cameras, access devices, appliances and other endpoint devices for enterprise, industrial and service-provider environments. Its solutions are categorized into Enterprise Technology and Service Provider Technology. The Company markets its products through distributors, value-added resellers, web stores, systems integrators, corporate IT professionals, and its Ubiquiti Community.
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.